苑东生物：盐酸纳呋拉啡口崩片获药品注册证书

Core Viewpoint - The company, Yuandong Biotech (688513), has received approval from the National Medical Products Administration for the drug registration certificate of hydrochloride nafurafine orally disintegrating tablets, indicating a significant advancement in its product pipeline [1] Company Summary - Yuandong Biotech has recently announced the approval of hydrochloride nafurafine orally disintegrating tablets, which are classified as a second-class psychotropic drug under national regulations [1] - The primary active ingredient, hydrochloride nafurafine, is indicated for the treatment of pruritus in patients undergoing hemodialysis, specifically for cases where existing treatments are ineffective [1]